...
首页> 外文期刊>Journal of interventional cardiac electrophysiology: an international journal of arrhythmias and pacing >Supraventricular arrhythmias limit effective cardiac resynchronization therapy: Diagnosis using intracardiac electrograms and device based pacing maneuvers.
【24h】

Supraventricular arrhythmias limit effective cardiac resynchronization therapy: Diagnosis using intracardiac electrograms and device based pacing maneuvers.

机译:室上性心律失常限制了有效的心脏再同步治疗:使用心内电描记图和基于设备的起搏动作进行诊断。

获取原文
获取原文并翻译 | 示例
           

摘要

Cardiac resynchronization therapy is an effective tool for the treatment of drug-refractory heart failure in patients with left ventricular dysfunction and inter/intra ventricular conduction delay. Supraventricular tachycardias may prevent effect delivery of this therapy. We report three cases in which effective therapy was limited by asymptomatic supraventricular tachycardia. Diagnostic pacing maneuvers were performed via the implanted device to determine the underlying arrhythmia mechanism. These cases highlight the importance of (1) treating supraventricular tachycardias before and after implantation of cardiac devices and (2) using device based programmed stimulation to diagnose the mechanism of supraventricular tachycardias.
机译:心脏再同步疗法是治疗左心功能不全和心室间/室内传导延迟的药物难治性心力衰竭的有效工具。室上性心动过速可能阻止这种疗法的效果。我们报告了三例有效治疗受到无症状性室上性心动过速的限制。通过植入式设备进行诊断性起搏操作,以确定潜在的心律不齐机制。这些案例强调了(1)在植入心脏装置之前和之后治疗室上性心动过速的重要性,以及(2)使用基于装置的程序化刺激来诊断室上性心动过速的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号